Prescription Drug Information: Diltiazem Hydrochloride (Page 5 of 5)

PRINCIPAL DISPLAY PANEL — 10 mL Vial Label

10 mL Single-dose Fliptop Vial

Diltiazem
HCl Injection

50 mg/10 mL
(5 mg/mL)

For Direct Intravenous
Bolus Injection and ContinuousIntravenous Infusion.

Principal Display Panel -- 10 mL Vial Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 mL Vial Carton

10 X 10 mL Single-dose Fliptop Vials
NDC 0409-1171 -02
Rx only

Diltiazem Hydrochloride Injection
50 mg/10 mL
(5 mg/mL)

For Direct Intravenous Bolus Injection and Continuous Intravenous Infusion.

Store Under Refrigeration(For full storage information, see back panel.)

Hospira

Principal Display Panel -- 10 mL Vial Carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 100 mg Vial Label

Single-dose
ADD-Vantageā„¢ Vial

Sterile Powder

Diltiazem HCl for Injection

For Continuous Intravenous Infusion
Not For Bolus

Equivalent to 100 mg Diltiazem HCl

Usual dosage: See insert.
Each vial contains lyophilized powder comprised
of 100 mg diltiazem hydrochloride and 75 mgMannitol USP.

Principal Display Panel -- 100 mg Vial Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 100 mg Vial Tray

10 Single-dose ADD-Vantageā„¢ Vials
Sterile Powder
Rx only
NDC 0409-4350-03
Contains 10 of NDC 0409-4350-13

Diltiazem HCl for Injection

For Continuous Intravenous Infusion
Not For Bolus Usual Dosage: See insert.

Equivalent to 100 mg Diltiazem HCl

Hospira

Principal Display Panel -- 100 mg Vial Tray
(click image for full-size original)
DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0409-1171
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DILTIAZEM HYDROCHLORIDE (DILTIAZEM) DILTIAZEM HYDROCHLORIDE 5 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
CITRIC ACID MONOHYDRATE 0.75 mg in 1 mL
TRISODIUM CITRATE DIHYDRATE 0.65 mg in 1 mL
SORBITOL 50 mg in 1 mL
WATER
SODIUM HYDROXIDE
HYDROCHLORIC ACID
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0409-1171-01 10 VIAL, SINGLE-DOSE in 1 CARTON contains a VIAL, SINGLE-DOSE (0409-1171-11)
1 NDC:0409-1171-11 5 mL in 1 VIAL, SINGLE-DOSE This package is contained within the CARTON (0409-1171-01)
2 NDC:0409-1171-02 10 VIAL, SINGLE-DOSE in 1 CARTON contains a VIAL, SINGLE-DOSE (0409-1171-12)
2 NDC:0409-1171-12 10 mL in 1 VIAL, SINGLE-DOSE This package is contained within the CARTON (0409-1171-02)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA074941 05/05/2006
DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0409-4350
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DILTIAZEM HYDROCHLORIDE (DILTIAZEM) DILTIAZEM HYDROCHLORIDE 100 mg
Inactive Ingredients
Ingredient Name Strength
MANNITOL 75 mg
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0409-4350-03 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY contains a VIAL, PATENT DELIVERY SYSTEM (0409-4350-13)
1 NDC:0409-4350-13 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM This package is contained within the TRAY (0409-4350-03)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075853 04/30/2005
Labeler — Hospira, Inc. (141588017)
Establishment
Name Address ID/FEI Operations
Hospira, Inc. 030606222 ANALYSIS (0409-1171), ANALYSIS (0409-4350), MANUFACTURE (0409-1171), MANUFACTURE (0409-4350), PACK (0409-1171), PACK (0409-4350), LABEL (0409-1171), LABEL (0409-4350)
Establishment
Name Address ID/FEI Operations
Hospira, Inc. 827731089 ANALYSIS (0409-1171), ANALYSIS (0409-4350)

Revised: 04/2021 Hospira, Inc.

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Medication Sections

Medication Information by RSS

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.